<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments

Orthobiologics

Ending on a Bright Note: Q122 OrthoBio Market Recap

Q122 started slow but ended on a bright note as COVID-19 concerns faded and surgical volumes approached ...

Orthobiologics

Springing Back: Q122 US Joint Fluid Replacement Market Recap

US Viscosupplementation Market players march on the positive momentum of Q421 and Q122, putting the spri...

Orthopedics

Soft Tissue Fixation Rebounds: Q122 Market Recap

Soft Tissue Fixation Rebounds in Q122 After a slow end to 2021, Soft Tissue Fixation bounced back with p...

Regenerative Medicine

Trends To Watch in 2022: Injectable Regenerative Medicine Therapies

From the impact of stringent regulations to the shift toward new indications and rising market segments,...

Regenerative Medicine

Emerging Leaders in Regen Med: A Talk with Jointechlabs' CEO Nathan Katz

Jointechlabs – Emerging leader in point-of-care regenerative and rejuvenation medicine therapies Nathan ...

Orthobiologics

COVID-19 Headwinds: Q321 OrthoBio Market Recap

Renewed COVID-19 headwinds mute overall Q3 results, however, the soft tissue repair segment remains resi...

Orthobiologics

Bursting Bubbles: Q321 Joint Fluid Market Recap

Q321 results were a letdown compared to the previous quarter as COVID-19 continues to burst HA players’ ...

Orthobiologics

Q321 Market Recap: US Surgical Matrices

Procedures using surgical matrices maintained their new normal, with broad strength in both hernia and b...

Regenerative Medicine

Meet Jim Petricek - General Manager, Orthobiologics & Regenerative Medicine

We are pleased to announce that Jim Petricek has joined the team at SmartTRAK as General Manager, Orthob...

Top Story

Evolution is Inevitable: An Interview with Anika's Cheryl Blanchard, PhD

Cheryl Blanchard, President and CEO of Anika Therapeutics, discusses the Company’s metamorphosis from a ...

1
...
5 6 7 8 9